Optalert’s Johns Drowsiness Scale (JDS) accurately quantifies impairment caused by drowsiness, surpassing competing technologies in predictive power. This post outlines how Optalert has been able to quantify the relative risk of a driver’s impairment from drowsiness with a unique biomarker. It is independent of age, gender, or ethnicity. These claims are substantiated through both internal...

Automotive Original Equipment Manufacturers (OEMs) can now achieve both EU General Safety Regulation (GSR) compliance and European New Car Assessment Programme (Euro NCAP) assessment using Optalert’s non-invasive Johns Drowsiness Scale (JDS™) as the ground truth. Numerous automotive technical services firms in Europe, including UTAC, TÜV Rheinland, and Applus+ IDIADA, have reviewed the evidence and confirmed...

When we commonly speak of drowsiness, we may use a range of terms interchangeably, such as fatigue, tiredness, or sleepiness. In common speech, this is fine. But for the purposes of understanding the underlying science, we need to be more precise around what each of these words mean. Drowsiness is not fatigue Fatigue is defined...

What is Optalert’s experience in measuring drowsiness in the field? How do we see this technology reaching maturity in the automotive sector? What is the difference between objective and subjective measures of drowsiness? How does Optalert see drowsiness measurement evolving in the future? In the lead-up to the InCabin conference in Phoenix next week, our...